Interpace Diagnostics Group Inc. buy melinda
Start price
23.10.17
/
50%
€13.60
Target price
26.12.17
€17.00
Performance (%)
-30.88%
End price
26.12.17
€9.40
Summary
This prediction ended on 26.12.17 with a price of €9.40. The BUY prediction by melinda for Interpace Diagnostics Group Inc. performed very badly with a performance of -30.88%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Interpace Diagnostics Group Inc. | - | - | - | - |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % | 49,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % | 82,05 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % | 60,62 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % | 59,66 % |
Comments by melinda for this prediction
In the thread Interpace Diagnostics Group Inc. diskutieren
Diagnose Interpace vorhanden wichtige Daten in der Gastroenterologie - Weltkongress des American College of Gastroenterology (ACG) 2017
Präsentationen PancraGEN® BarreGEN® und vom Kollegium angenommen
(Vom Mitglied beendet)
Stopped prediction by melinda for Interpace Diagnostics Group Inc.
Interpace Diagnostics Group Inc.
Start price
Target price
Perf. (%)
€12.27
23.10.17
23.10.17
€15.33
26.12.17
26.12.17
-30.88%
26.12.17
26.12.17
Interpace Diagnostics Group Inc.
Start price
Target price
Perf. (%)
€8.03
29.06.17
29.06.17
€15.33
24.08.17
24.08.17
40.45%
24.08.17
24.08.17
Interpace Diagnostics Group Inc.
Start price
Target price
Perf. (%)
€20.32
07.04.17
07.04.17
€30.67
18.04.17
18.04.17
68.51%
18.04.17
18.04.17